GAIN THERAPEUTICS INC
2.1350
07-十月-24 14:59:56
15 分钟延时
股票
+0.3150
+17.31%
今日范围
1.8260 - 2.1400
ISIN
N/A
来源
NASDAQ
-
12 9月 2023 08:25:00 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics Announces Second Quarter 2023 Financial Results and Business Update
10 8月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
07 8月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in the 2023 BTIG Virtual Biotechnology Conference
31 7月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics to Present at the Jefferies Healthcare Conference
01 6月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics Reports First Quarter 2023 Financial Results and Business Update
12 5月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
03 5月 2023 08:15:00 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
12 4月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics to Present Positive Preclinical Data on its GBA1 Program at the AD/PD 2023 Meeting
29 3月 2023 07:52:52 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update
23 3月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
22 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
21 3月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in the Oppenheimer 33rd Annual Healthcare Conference
09 3月 2023 07:00:03 条件 Nasdaq GlobeNewswire
-
27 2月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in Upcoming Scientific and Medical Conferences
02 2月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics to Present at Sidoti Small-Cap Virtual Investor Conference
12 1月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Business Update
10 11月 2022 15:02:00 条件 Nasdaq GlobeNewswire
-
26 9月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer
20 9月 2022 06:30:00 条件 Nasdaq GlobeNewswire